Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting
about
A Systematic Review of Point of Care Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalisChlamydia trachomatis Infection in Pregnancy: The Global Challenge of Preventing Adverse Pregnancy and Infant Outcomes in Sub-Saharan Africa and AsiaPoint-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directionsDiagnostic Procedures to Detect Chlamydia trachomatis InfectionsDiagnosis and Management of Uncomplicated Chlamydia trachomatis Infections in Adolescents and Adults: Summary of Evidence Reviewed for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment GuidelinesPoint of care diagnostics for sexually transmitted infections: perspectives and advancesYoung people's perceptions of smartphone-enabled self-testing and online care for sexually transmitted infections: qualitative interview study.Rapid detection and strain typing of Chlamydia trachomatis using a highly multiplexed microfluidic PCR assay.Review of use of a new rapid real-time PCR, the Cepheid GeneXpert® (Xpert) CT/NG assay, for Chlamydia trachomatis and Neisseria gonorrhoeae: results for patients while in a clinical setting.Mobile nucleic acid amplification testing (mobiNAAT) for Chlamydia trachomatis screening in hospital emergency department settingsExisting and Emerging Technologies for Point-of-Care Testing.Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.A new rapid molecular point-of-care assay for Trichomonas vaginalis: preliminary performance data.Highly sensitive and novel point-of-care system, aQcare Chlamydia TRF kit for detecting Chlamydia trachomatis by using europium (Eu) (III) chelated nanoparticles.Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay.A research protocol for developing a Point-Of-Care Key Evidence Tool 'POCKET': a checklist for multidimensional evidence reporting on point-of-care in vitro diagnostics.The Point-of-Care Laboratory in Clinical Microbiology.Blind evaluation of the microwave-accelerated metal-enhanced fluorescence ultrarapid and sensitive Chlamydia trachomatis test by use of clinical samples.National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network: Advancing Precision MedicineAn early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in EnglandCost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States.Impact of deploying multiple point-of-care tests with a 'sample first' approach on a sexual health clinical care pathway. A service evaluation.Prevalence of Curable Sexually Transmitted Infections in Pregnant Women in Low- and Middle-Income Countries From 2010 to 2015: A Systematic Review.Evaluating 3D printing to solve the sample-to-device interface for LRS and POC diagnostics: example of an interlock meter-mix device for metering and lysing clinical urine samples.Trends in ectopic pregnancy rates following assisted reproductive technologies in the UK: a 12-year nationwide analysis including 160 000 pregnancies.Background review for the '2015 European guideline on the management of Chlamydia trachomatis infections'.2015 UK national guideline for the management of infection with Chlamydia trachomatis.Identifying a need for more focused treatment of chlamydia and gonorrhoea in the emergency department.The performance of non-NAAT point-of-care (POC) tests and rapid NAAT tests for chlamydia and gonorrhoea infections. An assessment of currently available assays.Point-of-care management of urogenital Chlamydia trachomatis via Gram-stained smear analysis in male high-risk patients. Diagnostic accuracy and cost-effectiveness before and after changing the screening indication at the STI Clinic in Amsterdam.Point-of-Care Diagnostics in Low-Resource Settings and Their Impact on Care in the Age of the Noncommunicable and Chronic Disease Epidemic.[Modern diagnosis of sexually transmitted diseases].Cost-Benefit Analysis of a Chlamydia trachomatis Vaccine Program in Adolescent Girls in the United States.Holistic actions are essential to combat the global public health burden of non-viral sexually transmitted infections: challenges and future perspectives.Schnelltest-Diagnostik sexuell übertragbarer Infektionen in niedrigschwelligen Einrichtungen : Gemeinsame Stellungnahme des RKI, PEI und der DSTIG.Economic evaluation of medical tests at the early phases of development: a systematic review of empirical studies.Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary medicine clinic attendees
P2860
Q26745607-12020A07-5C5C-4CA2-BF28-9C935D274927Q26752829-296D44C5-75F5-45CA-942C-D96419CB3638Q27000391-2BED537F-D055-43B4-8A9D-C2B6F67B755EQ28066097-00259511-9279-436E-92B7-769FA5710CA8Q28082170-5F7F6DD6-F22D-4BDB-AB5D-1401D8331401Q30436304-CE24EFDA-C69D-4239-80DB-85B6D3E5145DQ30811015-D6A0FBF5-B49F-427E-A4D8-97D52339B692Q33746002-41335A37-70E0-4C64-BFB2-04EF62F024C0Q33770782-FC45FC4A-69A4-40AF-AB82-AE68A5B7ECB3Q33866746-828AD531-618C-4762-96A3-40F94676A294Q34376474-A73B548C-3912-4EA3-9204-A2F7C73489D4Q34610728-6255338E-5871-406F-8D14-F1C77C0CA954Q34680201-AA09D019-0BC6-421F-9C00-A55BD3B72DC5Q34749687-F6B012E4-F2FC-41DC-9FFF-3DCCADFA4734Q35252166-BC7BBBAF-F5D0-4AE8-9A07-7830E90D49B5Q35844147-CF41F338-9497-4D9F-99CD-19A0EF30E42AQ36886416-D3DF67BD-9F51-40D4-9016-ED6EF338FE90Q37125196-19576330-ACB8-4ED3-959E-DA6B0DA38C5DQ37313602-30A032BB-EAEB-473D-AAA1-9CD68A3DD0FBQ37599522-7DE9FCC2-075C-4228-866A-CF52FD193060Q37650849-C189CD1D-1BDB-4187-BE41-2A1E28A25D00Q37835010-DC463AE9-0DBF-450E-827C-BA628E3453ABQ37836107-A5EC0E25-1B30-4461-9C31-0DE7E44460CDQ37836592-5401C1E3-9AE5-47D1-B135-B49B0BD2BFA8Q37838105-5C0F31A1-8E78-4CB9-8EB3-FB24B3F3EAE6Q37838405-12FA5A6D-4038-4CED-B49A-43E7C4EC29C3Q37838564-ECCF092D-0CAE-4370-9771-D556A398E2ABQ37839012-F0737A25-A889-4C8C-8BC4-7D40301F8B7FQ37840832-13A29DBB-9F2A-4070-B1FD-C09C9A8A58EDQ37841164-1422110D-434C-47E3-9026-5C4BA59DF207Q38173718-D0F1FA01-BCF2-489E-867D-B0AD961B1BD3Q40879173-CD6967D6-4DC0-4E02-AF1A-A278965DE4EAQ41989587-347D8E92-949B-4D56-A98A-23C13C8511A1Q43408824-995D9090-5B4A-4151-AD49-5147A605313AQ45030352-94766E24-7866-4255-A03B-CFD0D2C63B3CQ47813585-4E10EC82-2A4B-45B6-86EE-807EEE649863Q58753889-D8999D77-576D-4DF1-B1FA-47B6585AF63E
P2860
Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Comparative effectiveness of a ...... ng women in a clinical setting
@en
type
label
Comparative effectiveness of a ...... ng women in a clinical setting
@en
prefLabel
Comparative effectiveness of a ...... ng women in a clinical setting
@en
P2093
P2860
P1476
Comparative effectiveness of a ...... ng women in a clinical setting
@en
P2093
Diane R Blake
Mary Jett-Goheen
Mathilda R Barnes
P2860
P304
P356
10.1136/SEXTRANS-2011-050355
P577
2012-09-14T00:00:00Z